[
antibody response
]
Oxford says Covid-19 vaccine has good immune response with 2-dose regime
By Reuters | Posted by Prashasti Singh | Washington
UPDATED ON DEC 18, 2020 06:17 AM IST
The vaccine candidate, which has been licensed to AstraZeneca, has published interim late stage trial results showing higher efficacy when a half dose is followed by a full dose, compared to a two full-dose regime, though more work needs to be done to affirm the result.
Long-term immunity in doubt as UK study finds Covid-19 antibodies fall rapidly
By Press Trust of India | Posted by Nilavro Ghosh | London
UPDATED ON OCT 27, 2020 04:20 PM IST
The Imperial College London team found the number of people testing positive with a finger-prick test for antibodies has fallen by 26 per cent between June and September.
Healthwise: Why outbreaks occur, and how to stop them
By Sanchita Sharma | Hindustan Times, Delhi, New Delhi
UPDATED ON FEB 17, 2019 06:03 PM IST
Extreme temperature and unseasonal rain have expanded the geographical breeding grounds of vectors such as mosquitoes, leading to perennial infection of a few vector-borne diseases such as malaria and dengue.
People with gum disease at risk of developing rheumatoid arthritis
By Indo Asian News Service | Indo Asian News Service, London
UPDATED ON JUN 17, 2018 12:37 PM IST
Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, causing pain and disability and can also affect internal organs.